Clinical Trial Update: Decitabine and Nivolumab in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating decitabine in combination with nivolumab for recurrent/metastatic head and neck squamous cell carcinoma; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Dacogen (decitabine)
• OPDIVO (nivolumab)

Snippet

Sponsor: Kyunghee Burkitt, DO, PhD | Conditions: Head and Neck Cancer, Head and Neck Neoplasms | Phase 1 | Status: NOT_YET_RECRUITING